Nezallix (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine blocks H1 histamine receptors, preventing the immediate allergic response that leads to itching and sneezing. Fluticasone activates glucocorticoid receptors, suppressing inflammatory cytokines and reducing swelling of the nasal mucosa, providing longer‑lasting symptom control.

The prescribed dose of Nezallix is determined by a qualified healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and not alter the dosing regimen on their own.

Safety data for Nezallix in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Nezallix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nezallix combines an antihistamine (azelastine) with a corticosteroid (fluticasone) in a single spray, offering both rapid symptom relief and sustained anti‑inflammatory action. Single‑agent sprays contain either an antihistamine or a steroid, which may require separate products to achieve comparable control.

Nezallix should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and avoid freezing the product.

Nezallix is administered as a nasal spray. The patient gently inserts the nozzle into each nostril and sprays the prescribed number of sprays, usually once or twice daily, while keeping the head upright. Detailed instructions are provided by the prescriber.

Serious risks, though rare, include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic corticosteroid effects like adrenal suppression. Patients should seek immediate medical attention if they experience unusual bleeding, vision changes, or signs of a severe allergic response.

Nezallix should be avoided in individuals with known hypersensitivity to azelastine, fluticasone, or any component of the formulation. It is also contraindicated in patients who require multiple intranasal corticosteroids simultaneously, unless specifically directed by a physician.